Attila Pethö‐Schramm

1.1k citations

34 papers · 658 indexed · h-index 12

Co-authors: Hans‐Joachim Müller Christoph Brunner Victor W. Armstrong Marion Helmhold Francesco Paolo Mancini Helen H. Hobbs Eric Boerwinkle Rudy Guerra
Topics: Rheumatoid Arthritis Research and Therapies (23 papers)Systemic Lupus Erythematosus Research (10 papers)Chronic Lymphocytic Leukemia Research (8 papers)
Cited by: Rheumatology Hematology Cancer Research
Journals: Journal of Biological Chemistry PLoS ONE The FASEB Journal
Partner nations: Switzerland Netherlands United States

In The Last Decade

Attila Pethö‐Schramm

33 papers receiving 648 citations

Peers

Countries citing papers authored by Attila Pethö‐Schramm

Since Specialization

Citations

This map shows the geographic impact of Attila Pethö‐Schramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attila Pethö‐Schramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attila Pethö‐Schramm more than expected).

Fields of papers citing papers by Attila Pethö‐Schramm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attila Pethö‐Schramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attila Pethö‐Schramm. The network helps show where Attila Pethö‐Schramm may publish in the future.

Co-authorship network of co-authors of Attila Pethö‐Schramm

This figure shows the co-authorship network connecting the top 25 collaborators of Attila Pethö‐Schramm. A scholar is included among the top collaborators of Attila Pethö‐Schramm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attila Pethö‐Schramm. Attila Pethö‐Schramm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis 2021 ·BMJ Open ·Sanjoy K. Paul,Olga Montvida,Jennie H. Best,Sara Gale,Attila Pethö‐Schramm,Khaled Sarsour	3
2	Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis 2021 ·Journal of Patient-Reported Outcomes ·Jeffrey R. Curtis,(unknown),(unknown),Christine de la Loge,Benoît Arnould,Robert A. Davey,Jenny Devenport,Attila Pethö‐Schramm	3
3	Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab 2020 ·PLoS ONE ·Xavier M Teitsma,Jenny Devenport,Johannes W. G. Jacobs,Attila Pethö‐Schramm,Michelle E A Borm,Petra Budde,J. W. J. Bijlsma,Floris P. J. G. Lafeber	3
4	Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis 2020 ·The Journal of Rheumatology ·(unknown),Janneke Tekstra,Jacob M. van Laar,Attila Pethö‐Schramm,Michelle E A Borm,J. W. J. Bijlsma,Johannes W. G. Jacobs,Floris P. J. G. Lafeber,Paco M J Welsing	4
5	Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics. 2019 ·PubMed ·Xavier M Teitsma,Johannes W G Jacobs,(unknown),Attila Pethö‐Schramm,Michelle E A Borm,Jacob M. van Laar,J. W. J. Bijlsma,Floris P. J. G. Lafeber	5
6	Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology 2018 ·Arthritis Research & Therapy ·Xavier M Teitsma,Wei Yang,Johannes W. G. Jacobs,Attila Pethö‐Schramm,Michelle E A Borm,Amy C. Harms,Thomas Hankemeier,Jacob M. van Laar,J. W. J. Bijlsma,Floris P. J. G. Lafeber	29
7	Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors 2018 ·Annals of the Rheumatic Diseases ·Xavier M Teitsma,Johannes W. G. Jacobs,Paco M J Welsing,Pascal H P de Jong,Johanna M. W. Hazes,A. Weel,Attila Pethö‐Schramm,Michelle E A Borm,Jacob M. van Laar,Floris P. J. G. Lafeber,J. W. J. Bijlsma	32
8	Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis 2018 ·Lara D. Veeken ·Ernest Choy,Roberto Caporali,Ricardo Machado Xavier,Bruno Fautrel,Raimón Sanmartí,Min Bao,Jenny Devenport,Attila Pethö‐Schramm	9
9	Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy 2017 ·Lara D. Veeken ·Xavier M Teitsma,Johannes W. G. Jacobs,Paco M J Welsing,Attila Pethö‐Schramm,Michelle E A Borm,(unknown),(unknown),Jacob M. van Laar,Floris P. J. G. Lafeber,J. W. J. Bijlsma	6
10	OP0293 Weighted gene co-expression network analysis of DMARD-NAÏVE early ra patients achieving sustained drug-free remission after initiating tocilizumab therapy 2017 ·Annals of the Rheumatic Diseases ·(unknown),(unknown),(unknown),Attila Pethö‐Schramm,(unknown),JM van Laar,(unknown),(unknown)	1
11	Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy 2017 ·Arthritis Research & Therapy ·Xavier M Teitsma,Johannes W. G. Jacobs,Michal Mokrý,Michelle E A Borm,Attila Pethö‐Schramm,Jacob M. van Laar,J. W. J. Bijlsma,Floris P. J. G. Lafeber	14
12	Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies 2017 ·Lara D. Veeken ·Xavier M Teitsma,Johannes W. G. Jacobs,Paco M J Welsing,Attila Pethö‐Schramm,Michelle E A Borm,Jacob M. van Laar,Floris P. J. G. Lafeber,J. W. J. Bijlsma	14
13	FRI0215 Subcutaneous Tocilizumab as Monotherapy or in Combination with A csDMARDs in Patients with Rheumatoid Arthritis – Interim Analysis of A Large Phase IV International Umbrella Study, “Tozura” 2016 ·Annals of the Rheumatic Diseases ·Ernest Choy,Roberto Caporali,Ricardo Machado Xavier,Bruno Fautrel,Raimón Sanmartí,Corrado Bernasconi,Attila Pethö‐Schramm	4
14	FGF5 and the murine hair cycle 1996 ·Archives of Dermatological Research ·Attila Pethö‐Schramm,(unknown),Ralf Paus	25
15	The Number of Identical Kringle IV Repeats in Apolipoprotein(a) Affects Its Processing and Secretion by HepG2 Cells 1996 ·Journal of Biological Chemistry ·Christoph Brunner,(unknown),Attila Pethö‐Schramm,(unknown),Chantal Kang,Hans Dieplinger,Hans‐Joachim Müller,Gerd Utermann	83
16	Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 32−36 of Human Apolipoprotein(a) 1995 ·Journal of Biological Chemistry ·(unknown),Marion Helmhold,Christoph Brunner,Attila Pethö‐Schramm,Victor W. Armstrong,Hans‐Joachim Müller	87
17	Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma 1995 ·Human Molecular Genetics ·Vincent Mooser,Francesco Paolo Mancini,(unknown),Attila Pethö‐Schramm,Rudy Guerra,Eric Boerwinkle,(unknown),Helen H. Hobbs	110
18	Reconstruction of Blood Flow Distribution in the Rat Kidney during Postischemic Renal Failure 1994 ·The Nephron journals/Nephron journals ·F. Vetterlein,(unknown),Attila Pethö‐Schramm,Gerhard Schmidt	4
19	Effects of diltiazem and allopurinol in postischemic microcirculatory changes in the rat kidney. 1991 ·PubMed ·Attila Pethö‐Schramm,(unknown),F. Vetterlein,Gerhard Schmidt	2
20	Increased accumulation of plasma albumin in the extracellular space of the heart during hypoxia. 1991 ·PubMed ·F. Vetterlein,Attila Pethö‐Schramm,(unknown)	3

About Attila Pethö‐Schramm

Attila Pethö‐Schramm is a scholar working on Rheumatology, Genetics and Hematology, having authored 34 papers that have together received 658 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (23 papers), Systemic Lupus Erythematosus Research (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Rheumatology (217 citations), Hematology (90 citations) and Cancer Research (115 citations). Attila Pethö‐Schramm has collaborated with scholars based in Switzerland, Netherlands and United States. Frequent co-authors include Hans‐Joachim Müller, Christoph Brunner, Victor W. Armstrong, Marion Helmhold, Francesco Paolo Mancini, Helen H. Hobbs, Eric Boerwinkle, Rudy Guerra, Vincent Mooser and Gerd Utermann. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact